However, depleting the circulating plasma concentration of α2-AP by use of antibodies, plasmin or microplasmin in permanent cerebral ischemia has been shown to reduce infarct volume [47] and/or improve behavior [48]. The gene discussed is SERPINF2; the disease is Cerebral ischemia.